{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T17:24:34Z","timestamp":1783790674500,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,1,14]],"date-time":"2010-01-14T00:00:00Z","timestamp":1263427200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s10147-009-0009-1","type":"journal-article","created":{"date-parts":[[2010,1,13]],"date-time":"2010-01-13T02:06:26Z","timestamp":1263348386000},"page":"46-51","source":"Crossref","is-referenced-by-count":21,"title":["A prospective open-label trial of gabapentin as an adjuvant analgesic with opioids for Japanese patients with neuropathic cancer pain"],"prefix":"10.1007","volume":"15","author":[{"given":"Hidenori","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohito","family":"Shimoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,14]]},"reference":[{"key":"9_CR1","volume-title":"Cancer pain relief with a guide to opioid availability","author":"World Health Organization","year":"1996","unstructured":"World Health Organization (1996) Cancer pain relief with a guide to opioid availability, 2nd edn. WHO, Geneva","edition":"2"},{"key":"9_CR2","first-page":"349","volume-title":"Adjuvant analgesics in pain management. Oxford Textbook of Palliative Medicine","author":"D Lussier","year":"2003","unstructured":"Lussier D, Portenoy RK (2003) Adjuvant analgesics in pain management. Oxford Textbook of Palliative Medicine, 3rd edn. Oxford University Press, New York, pp 349\u2013378","edition":"3"},{"key":"9_CR3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0304-3959(95)00017-M","volume":"63","author":"DFJ Zech","year":"1995","unstructured":"Zech DFJ, Grond S, Lynch J et al (1995) Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain 63:65\u201376","journal-title":"Pain"},{"key":"9_CR4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3959(99)00006-8","volume":"81","author":"RK Portenoy","year":"1999","unstructured":"Portenoy RK, Payne D, Jacobsen P (1999) Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 81:129\u2013134","journal-title":"Pain"},{"key":"9_CR5","volume-title":"Symptom management in advanced cancer","author":"R Twycross","year":"2001","unstructured":"Twycross R, Wilcock A (2001) Symptom management in advanced cancer, 3rd edn. Radcliffe Medical Press, Abingdon","edition":"3"},{"key":"9_CR6","volume-title":"Textbook of pain","author":"PD Wall","year":"2005","unstructured":"Wall PD, Melzack R (2005) Textbook of pain, 5th edn. Churchill Livingstone, Philadelphia","edition":"5"},{"key":"9_CR7","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","volume":"280","author":"M Backonja","year":"1998","unstructured":"Backonja M, Beydoun A, Edwards KR et al (1998) Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280:1831\u20131836","journal-title":"JAMA"},{"key":"9_CR8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","volume":"118","author":"NB Finnerup","year":"2005","unstructured":"Finnerup NB, Otto M, McQuay HJ et al (2005) Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118:289\u2013305","journal-title":"Pain"},{"key":"9_CR9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0304-3959(96)03140-5","volume":"68","author":"HJ McQuay","year":"1996","unstructured":"McQuay HJ, Tramer M, Nye BA et al (1996) A systematic review of antidepressants in neuropathic pain. Pain 68:217\u2013227","journal-title":"Pain"},{"key":"9_CR10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0304-3959(01)00407-9","volume":"94","author":"ASC Rice","year":"2001","unstructured":"Rice ASC, Maton S (2001) Gabapentin in postherpetic neuralgia: a randomized, double blind, placebo controlled study. Pain 94:215\u2013224","journal-title":"Pain"},{"key":"9_CR11","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","volume":"110","author":"J Rosenstock","year":"2004","unstructured":"Rosenstock J, Tuchman M, LaMoreaux L et al (2004) Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 110:628\u2013638","journal-title":"Pain"},{"key":"9_CR12","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.280.21.1837","volume":"280","author":"M Rowbotham","year":"1998","unstructured":"Rowbotham M, Harden N, Stacey B et al (1998) Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 280:1837\u20131842","journal-title":"JAMA"},{"key":"9_CR13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0304-3959(02)00255-5","volume":"99","author":"MG Serpell","year":"2002","unstructured":"Serpell MG (2002) Gabapentin in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial. Pain 99:557\u2013566","journal-title":"Pain"},{"key":"9_CR14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0304-3959(99)00154-2","volume":"83","author":"SH Sindrup","year":"1999","unstructured":"Sindrup SH, Jensen TS (1999) Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83:389\u2013400","journal-title":"Pain"},{"key":"9_CR15","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","volume":"352","author":"I Gilron","year":"2005","unstructured":"Gilron I, Bailey JM, Tu D et al (2005) Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 352:1324\u20131334","journal-title":"N Engl J Med"},{"key":"9_CR16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0885-3924(06)80004-7","volume":"7","author":"E Bruera","year":"1992","unstructured":"Bruera E, Ripamonti C, Brenneis C et al (1992) A randomized double-blind crossover trial of intravenous lidocaine in the treatment of neuropathic pain. J Pain Symptom Manage 7:138\u2013140","journal-title":"J Pain Symptom Manage"},{"key":"9_CR17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0885-3924(00)00194-9","volume":"20","author":"S Mercadante","year":"2000","unstructured":"Mercadante S, Arcuri E, Tirelli W et al (2000) Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized controlled, double-blind, crossover, double dose study. J Pain Symptom Manage 20:246\u2013262","journal-title":"J Pain Symptom Manage"},{"key":"9_CR18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/030089160208800310","volume":"88","author":"S Mercadante","year":"2002","unstructured":"Mercadante S (2002) Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study. Tumori 88:239\u2013242","journal-title":"Tumori"},{"key":"9_CR19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0885-3924(01)00420-1","volume":"23","author":"C Sinnott","year":"2002","unstructured":"Sinnott C (2002) Problems recruiting cancer patients to comparative clinical trial of drug treatments for neuropathic pain in palliative care. J Pain Symptom Manage 23:270\u2013272","journal-title":"J Pain Symptom Manage"},{"key":"9_CR20","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1124\/jpet.102.041574","volume":"303","author":"ZD Luo","year":"2002","unstructured":"Luo ZD, Calcutt NA, Higuera ES et al (2002) Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther 303:1199\u20131205","journal-title":"J Pharmacol Exp Ther"},{"key":"9_CR21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00000542-199801000-00028","volume":"88","author":"B Partridge","year":"1998","unstructured":"Partridge B, Chaplan SR, Sakamoto E et al (1998) Characterization of the effects of gabapentin and 3-isobutyl-gamma-aminobutyric acid on substance P-induced thermal hyperalgesia. Anesthesiology 88:196\u2013205","journal-title":"Anesthesiology"},{"key":"9_CR22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0304-3959(97)00065-1","volume":"72","author":"M Shimoyama","year":"1997","unstructured":"Shimoyama M, Shimoyama N, Inturrisi CE et al (1997) Gabapentin enhances the antinociceptive effects of spinal morphine in the rat tail-flick test. Pain 72:375\u2013382","journal-title":"Pain"},{"key":"9_CR23","doi-asserted-by":"crossref","unstructured":"Wiffen PJ, McQuay HJ, Edwards JE et al (2005) Gabapentin for acute and chronic pain. Cochrane database of systematic reviews issue 3. Art. No.: CD005452. doi: 10.1002\/14651858.CD005452","DOI":"10.1002\/14651858.CD005452"},{"key":"9_CR24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1191\/0269216304pm845ra","volume":"18","author":"MI Bennett","year":"2004","unstructured":"Bennett MI, Simpson KH (2004) Gabapentin in the treatment of neuropathic pain. Palliat Med 18:5\u201311","journal-title":"Palliat Med"},{"key":"9_CR25","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/sj.bjp.0701320","volume":"121","author":"MJ Field","year":"1997","unstructured":"Field MJ, Oles RJ, Lewis AS et al (1997) Gabapentin (Neurontin) and S-(+)-3-isobutyl-gaba represent a novel class of selective antihyperalgesic agents. Br J Pharmacol 121:1513\u20131522","journal-title":"Br J Pharmacol"},{"key":"9_CR26","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1074\/jbc.271.10.5768","volume":"271","author":"NS Gee","year":"1996","unstructured":"Gee NS, Brown JP, Dissanayake VU et al (1996) The novel anticonvulsant drug gabapentin binds to the \u03b12\u03b4 subunit of a calcium channel. J Biol Chem 271:5768\u20135776","journal-title":"J Biol Chem"},{"key":"9_CR27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0304-3959(99)00283-3","volume":"85","author":"M Shimoyama","year":"2000","unstructured":"Shimoyama M, Shimoyama N, Hori Y (2000) Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn. Pain 85:405\u2013414","journal-title":"Pain"},{"key":"9_CR28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/00000542-200203000-00020","volume":"96","author":"EA Matthews","year":"2002","unstructured":"Matthews EA, Dickenson AH (2002) A combination of gabapentin and morphine mediates enhanced inhibitory effects on dorsal horn neuronal responses in a rat model of neuropathy. Anesthesiology 96:633\u2013640","journal-title":"Anesthesiology"},{"key":"9_CR29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0885-3924(99)00033-0","volume":"17","author":"A Caraceni","year":"1999","unstructured":"Caraceni A, Zecca E, Martini C et al (1999) Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain. J Pain Symptom Manage 17:441\u2013445","journal-title":"J Pain Symptom Manage"},{"key":"9_CR30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0885-3924(00)00166-4","volume":"20","author":"A Chandler","year":"2000","unstructured":"Chandler A, Williams JE (2000) Gabapentin, an adjuvant treatment for neuropathic pain in a cancer hospital. J Pain Symptom Manage 20:82\u201386","journal-title":"J Pain Symptom Manage"},{"key":"9_CR31","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1200\/JCO.2004.08.141","volume":"22","author":"A Caraceni","year":"2004","unstructured":"Caraceni A, Zecca E, Bonezzi C et al (2004) Gabapentin for neuropathic cancer pain: a randomized controlled trial from the gabapentin cancer pain study group. J Clin Oncol 22:2909\u20132917","journal-title":"J Clin Oncol"},{"key":"9_CR32","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1089\/jpm.2005.8.1118","volume":"8","author":"JR Ross","year":"2005","unstructured":"Ross JR, Goller K, Hardy J et al (2005) Gabapentin is effective in the treatment of cancer-related neuropathic pain: a prospective, open-label study. J Palliat Med 8:1118\u20131126","journal-title":"J Palliat Med"},{"key":"9_CR33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpainsymman.2006.11.013","volume":"34","author":"K Keskinbora","year":"2007","unstructured":"Keskinbora K, Pekel AF, Aydinli I (2007) Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: a randomized open trial. J Pain Symptom Manage 34:183\u2013189","journal-title":"J Pain Symptom Manage"},{"key":"9_CR34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1754-3207(08)60006-1","volume":"1","author":"H Takahashi","year":"2007","unstructured":"Takahashi H, Toya M, Shuto M et al (2007) The development of cancer pain management and palliative care over the last 5\u00a0years in Japan. Eur J Pain Suppl 1:14\u201318","journal-title":"Eur J Pain Suppl"},{"key":"9_CR35","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0885-3924(98)00098-0","volume":"16","author":"J Uki","year":"1998","unstructured":"Uki J, Mendoza T, Cleeland CS et al (1998) A brief cancer pain assessment tool in Japanese: the utility of the Japanese brief pain inventory-BPI-J. J Pain Symptom Manage 16:364\u2013373","journal-title":"J Pain Symptom Manage"},{"key":"9_CR36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3959(87)91074-8","volume":"30","author":"R Melzack","year":"1987","unstructured":"Melzack R (1987) The short-form McGill pain Questionnaire. Pain 30:191\u2013197","journal-title":"Pain"},{"key":"9_CR37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","volume":"94","author":"JT Farrar","year":"2001","unstructured":"Farrar JT, Young JP, LaMoreaux L et al (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94:149\u2013158","journal-title":"Pain"},{"key":"9_CR38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0304-3959(00)00339-0","volume":"88","author":"JT Farrar","year":"2000","unstructured":"Farrar JT, Portenoy RK, Berlin JA et al (2000) Defining the clinically important difference in pain outcome measures. Pain 88:287\u2013294","journal-title":"Pain"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-009-0009-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-009-0009-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-009-0009-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:24:50Z","timestamp":1559147090000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-009-0009-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,14]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["9"],"URL":"https:\/\/doi.org\/10.1007\/s10147-009-0009-1","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,14]]}}}